- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x GJ0: (2S)-2-azanyl-4-[[4-[2-bromanyl-4,5-bis(fluoranyl)phenoxy]phenyl]amino]-4-oxidanylidene-butanoic acid(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
Y01.2: 11 residues within 4Å:- Chain A: R.115, T.118, R.119, V.122, Y.123, S.126, I.130, I.335, V.339, L.496
- Ligands: PC1.3
8 PLIP interactions:8 interactions with chain A- Hydrophobic interactions: A:R.115, A:R.119, A:Y.123, A:I.335, A:I.335, A:V.339, A:L.496
- Salt bridges: A:R.119
Y01.15: 10 residues within 4Å:- Chain B: R.115, T.118, R.119, V.122, Y.123, S.126, I.130, I.335, L.496
- Ligands: PC1.16
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:R.119, B:Y.123, B:I.335, B:I.335, B:L.496
- Salt bridges: B:R.119
Y01.29: 10 residues within 4Å:- Chain C: R.115, T.118, R.119, V.122, Y.123, S.126, I.130, I.335, L.496
- Ligands: PC1.30
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:R.119, C:Y.123, C:I.335, C:I.335, C:L.496
- Salt bridges: C:R.119
- 30 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
PC1.3: 2 residues within 4Å:- Chain A: V.122
- Ligands: Y01.2
Ligand excluded by PLIPPC1.4: 3 residues within 4Å:- Chain A: K.111, M.121, V.122
Ligand excluded by PLIPPC1.5: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPC1.6: 5 residues within 4Å:- Chain A: V.133, L.140, I.425, V.426, S.429
Ligand excluded by PLIPPC1.7: 7 residues within 4Å:- Chain A: L.243, I.246, G.247, A.251, K.258
- Chain B: M.283
- Ligands: PC1.13
Ligand excluded by PLIPPC1.8: 9 residues within 4Å:- Chain A: L.96, I.97, S.100, L.101, L.108, L.434, V.437, S.441, T.449
Ligand excluded by PLIPPC1.9: 4 residues within 4Å:- Chain A: L.324, F.348, W.355, M.477
Ligand excluded by PLIPPC1.10: 3 residues within 4Å:- Chain A: K.40, L.41, N.44
Ligand excluded by PLIPPC1.11: 1 residues within 4Å:- Chain A: L.47
Ligand excluded by PLIPPC1.13: 9 residues within 4Å:- Chain A: L.175, F.176, A.251
- Chain B: M.88, M.91, M.283, I.284, W.286
- Ligands: PC1.7
Ligand excluded by PLIPPC1.16: 3 residues within 4Å:- Chain B: V.122, S.126
- Ligands: Y01.15
Ligand excluded by PLIPPC1.17: 4 residues within 4Å:- Chain B: K.111, T.118, M.121, V.122
Ligand excluded by PLIPPC1.18: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPC1.19: 4 residues within 4Å:- Chain B: V.133, L.140, I.425, V.426
Ligand excluded by PLIPPC1.20: 6 residues within 4Å:- Chain B: L.243, I.246, G.247, I.254
- Chain C: M.283
- Ligands: PC1.26
Ligand excluded by PLIPPC1.21: 9 residues within 4Å:- Chain B: L.96, S.100, L.101, L.108, N.274, L.434, V.437, S.441, T.449
Ligand excluded by PLIPPC1.22: 4 residues within 4Å:- Chain B: L.324, F.348, W.355, M.477
Ligand excluded by PLIPPC1.23: 2 residues within 4Å:- Chain B: K.40, K.43
Ligand excluded by PLIPPC1.24: 1 residues within 4Å:- Chain B: L.47
Ligand excluded by PLIPPC1.26: 9 residues within 4Å:- Chain B: L.175, F.176, A.251
- Chain C: M.88, M.91, M.283, I.284, W.286
- Ligands: PC1.20
Ligand excluded by PLIPPC1.27: 8 residues within 4Å:- Chain A: M.88, M.91, M.283, I.284, W.286
- Chain C: F.176, A.251
- Ligands: PC1.34
Ligand excluded by PLIPPC1.30: 3 residues within 4Å:- Chain C: V.122, S.126
- Ligands: Y01.29
Ligand excluded by PLIPPC1.31: 4 residues within 4Å:- Chain C: K.111, T.118, M.121, V.122
Ligand excluded by PLIPPC1.32: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPPC1.33: 4 residues within 4Å:- Chain C: V.133, L.140, I.425, S.429
Ligand excluded by PLIPPC1.34: 8 residues within 4Å:- Chain A: M.283
- Chain C: L.175, L.243, I.246, A.251, I.254, K.258
- Ligands: PC1.27
Ligand excluded by PLIPPC1.35: 10 residues within 4Å:- Chain C: L.96, I.97, S.100, L.108, N.274, L.434, V.437, S.441, T.449, L.452
Ligand excluded by PLIPPC1.36: 4 residues within 4Å:- Chain C: L.324, F.348, W.355, M.477
Ligand excluded by PLIPPC1.37: 3 residues within 4Å:- Chain C: K.40, L.41, N.44
Ligand excluded by PLIPPC1.38: 1 residues within 4Å:- Chain C: L.47
Ligand excluded by PLIP- 3 x XKJ: dodecyl beta-D-glucopyranoside(Non-covalent)
XKJ.12: 11 residues within 4Å:- Chain A: L.47, T.50, V.51, V.54, I.55, V.468, A.469, D.471, W.472, D.475
- Ligands: GJ0.1
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:I.55, A:W.472
- Hydrogen bonds: A:D.475, A:D.475
XKJ.25: 11 residues within 4Å:- Chain B: L.47, T.50, V.51, V.54, I.55, V.468, A.469, D.471, W.472, D.475
- Ligands: GJ0.14
5 PLIP interactions:5 interactions with chain B- Hydrophobic interactions: B:T.50, B:I.55, B:W.472
- Hydrogen bonds: B:D.475, B:D.475
XKJ.39: 11 residues within 4Å:- Chain C: L.47, T.50, V.51, V.54, I.55, V.468, A.469, D.471, W.472, D.475
- Ligands: GJ0.28
5 PLIP interactions:5 interactions with chain C- Hydrophobic interactions: C:T.50, C:I.55, C:W.472
- Hydrogen bonds: C:D.475, C:D.475
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Z. et al., Structural basis of ligand binding modes of human EAAT2. Nat Commun (2022)
- Release Date
- 2022-06-22
- Peptides
- Excitatory amino acid transporter 2: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x GJ0: (2S)-2-azanyl-4-[[4-[2-bromanyl-4,5-bis(fluoranyl)phenoxy]phenyl]amino]-4-oxidanylidene-butanoic acid(Non-covalent)
- 3 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 30 x PC1: 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 3 x XKJ: dodecyl beta-D-glucopyranoside(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, Z. et al., Structural basis of ligand binding modes of human EAAT2. Nat Commun (2022)
- Release Date
- 2022-06-22
- Peptides
- Excitatory amino acid transporter 2: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C - Membrane
-
We predict this structure to be a membrane protein.